Abstract:Abstract Introduction Methadone treatment for opioid use disorder (OUD) reduces drug cravings and promotes abstinence, but sleep disturbances can negatively impact OUD recovery outcomes. Irregular sleep architecture and respiratory disturbance in outpatients administered methadone as medication for OUD (MOUD) are common, but inter-individual differences may be substantial. We investigated the magnitude and stability of inter-individual differences in sleep architecture and respiratory measures in outpatients in their first 90 days of MOUD treatment. Methods N=6 adults (42.5±10.4y, four females) enrolled in local MOUD programs participated in this research study. The daily methadone dose varied between participants (75.8±23.2mg, range 50-120mg). All participants reported past use of multiple substances; four reported current mental health disorders; and four reported chronic pain. As part of the study, participants underwent two consecutive nights of cardiorespiratory PSG, with lights off at 21:49 on average (range 21:17-22:16) on both nights. Sleep stages and apnea-hypopnea index (AHI) were analyzed for systematic inter-individual differences using variance components analysis. The stability of inter-individual differences was quantified with the intraclass correlation coefficient (ICC, ranging from 0 to 1 for negligible to complete stability). Results On night one, mean±SD was 441.9±21.1min for total sleep time (TST), 9.0±5.2min for sleep latency (SL), 35.3±22.4min for wakefulness after sleep onset (WASO), 28.8±26.6min for N1, 220.8±58.6min for N2, 114.0±77.2min for N3, and 78.3±65.6min for REM. AHI scores were 16.4±9.1, indicating moderate sleep apnea on average. Compared to similarly aged healthy adults, N1 was low, and TST, WASO, N2, REM, and AHI were high. Stability was significant and substantial for N1, N2, REM, and AHI (ICC≥0.68, F≥5.19, P< 0.05). Conclusion Despite small sample size, we found substantial, stable inter-individual differences in N1, N2, REM, and AHI, whereas TST, SL, WASO, and N3 did not reach statistical significance. Varying methadone doses, prior substance use, physical and mental health, chronic pain, and (epi)genetic predisposition may partially account for these inter-individual differences. Our PSG data were collected in-laboratory, not naturalistically; results should be interpreted accordingly. Given the substantial, stable inter-individual differences in sleep architecture, a personalized approach to sleep management may be crucial to help improve OUD recovery outcomes. Support (if any) WSU ORAP and HSCL

Efficacy observation of zolpidem in improvement of sleep quality of patients received methadone maintenance treatment

Efficacy and Safety of Zolpidem in Treatment of Primary Insomnia in Chinese Elderly: an Open, Selfcontrolled, Multicenter Study

Comparing the Effects of Melatonin and Zolpidem on Mental Health and Sexual Function in Men With Opioid Addiction: Evidence From a Randomized Clinical Trial

The Efficacy of Combined Electroacupuncture and Auricular Pressure on Sleep Quality in Patients Receiving Methadone Maintenance Treatment

Effect and reliability of zaleplon on treatment of insomnia:a randomized,double-blind,controll study

The relationship between alertness and sleep in a population of 769 elderly insomniacs with and without treatment with zolpidem

Durability of treatment response to zolpidem with three different maintenance regimens: a preliminary study

Sleeping Problems in Chinese Illicit Drug Dependent Subjects

Treatment of insomnia in myasthenia gravis-A prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia

Gender Differences in Sleep Problems among Drug Users

Study on the Effect of Zopiclone and Eszopiclone in the Treatment of Insomniac Patients by Polysomnogram

Effect of Huo Li Su Oral Solution Combined with Zopiclone in the Treatment of Insomnia Symptoms

A multicenter,randomized,double-blind,controlled clinical trial of domestic zaleplon for insomnia

Analysis of the Clinical Effect of Chinese Medicine Combined with Acupuncture and Moxibustion on Insomnia

Efficacy and Safety of Eszopiclone in 2-week Treatment of Primary Insomnia:a Randomized,Double-blind,Zopiclone-controlled Multicenter Trial

Clinical Efficacy and Safety of 16 Chinese Patent Medicines in Combination with Benzodiazepines/Non-Benzodiazepines for the Treatment of Chronic Insomnia in Adults: A Multiple-Treatment Meta-Analysis

0986 Inter-Individual Differences in Sleep Architecture of Patients Receiving Methadone for Opioid Use Disorder

Efficacy and Safety of Eszopiclone in the Treatment of Insomnia

Efficacy of Moxibustion on Back-Shu Points for Chronic Insomnia: A Randomized Controlled Clinical Trail

Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia

The Clinical Effects of Zhenma Compound Capsule on Patients with Insomnia